Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bogdan Paun

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Plos One|June 26, 2008
Generation of small 32P-labeled peptides as a potential approach to colorectal cancer therapyJohn M Abraham, Yulan Cheng, James P Hamilton, et al.
Biochemical and Biophysical Research Communications|February 21, 2006
Polo-like kinase and survivin are esophageal tumor-specific promotersFumiaki Sato, John M Abraham, Jing Yin, et al.
Gastroenterology|September 6, 2006
A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancerYuriko Mori, Kun Cai, Yulan Cheng, et al.
Cancer Research|May 3, 2008
Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinomaTetsuo Ito, Yutaka Shimada, Takatsugu Kan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2008
Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progressionZhe Jin, James P Hamilton, Jian Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancerZhe Jin, Alexandru Olaru, Jian Yang, et al.
International Journal of Cancer|August 30, 2008
Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factorsZhe Jin, Yulan Cheng, Alexandru Olaru, et al.
Inflammatory Bowel Diseases|September 18, 2010
Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformationAlexandru V Olaru, Florin M Selaru, Yuriko Mori, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2006
Promoter methylation and response to chemotherapy and radiation in esophageal cancerJames P Hamilton, Fumiaki Sato, Bruce D Greenwald, et al.
Research Square|November 24, 2025
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AMLTheodoros Karantanos, Nour Naji, Taha Ahmedna, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Plos One|June 26, 2008
Generation of small 32P-labeled peptides as a potential approach to colorectal cancer therapyJohn M Abraham, Yulan Cheng, James P Hamilton, et al.
Biochemical and Biophysical Research Communications|February 21, 2006
Polo-like kinase and survivin are esophageal tumor-specific promotersFumiaki Sato, John M Abraham, Jing Yin, et al.
Gastroenterology|September 6, 2006
A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancerYuriko Mori, Kun Cai, Yulan Cheng, et al.
Cancer Research|May 3, 2008
Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinomaTetsuo Ito, Yutaka Shimada, Takatsugu Kan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2008
Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progressionZhe Jin, James P Hamilton, Jian Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancerZhe Jin, Alexandru Olaru, Jian Yang, et al.
International Journal of Cancer|August 30, 2008
Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factorsZhe Jin, Yulan Cheng, Alexandru Olaru, et al.
Inflammatory Bowel Diseases|September 18, 2010
Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformationAlexandru V Olaru, Florin M Selaru, Yuriko Mori, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2006
Promoter methylation and response to chemotherapy and radiation in esophageal cancerJames P Hamilton, Fumiaki Sato, Bruce D Greenwald, et al.
Research Square|November 24, 2025
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AMLTheodoros Karantanos, Nour Naji, Taha Ahmedna, et al.
Pageof 3